DOI: 10.36347/sajp

Pages: 222-225

Alzheimer’s disease is characterised by progressive loss of memory which is episodic in nature. Numerous drugs have been utilised for its treatment like cholinesterase inhibitors, NMDA antagonists etc but none of them have been effective in controlling the disease symptoms & progression. Numerous recent developments have concentrated upon targeting the β amyloid deposition & tau protein deposition in Alzheimer’s disease. This review attempts to provide information about the latest targets & developments in treatment of Alzheimer’s disease.